共 247 条
[1]
Abul-Husn NS(2014)Implementation and utilization of genetic testing in personalized medicine Pharmgenomics Pers Med 13 987-995
[2]
Obeng AO(2011)Personalizing medicine with clinical pharmacogenetics Genet Med 166C 45-55
[3]
Sanderson SC(2014)PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics Am J Med Genet C Semin Med Genet 92 87-95
[4]
Gottesman O(2012)Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project Clin Pharmacol Ther 274 29-34
[5]
Scott SA(1995)Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group JAMA 13 34-43
[6]
Scott SA(2007)The survey for the actual condition of drug medication and development of health care cost associated with toxic liver injury in Korean: a multicenter study for the detection and the development of nationwide reporting system of toxic liver injury Korean J Hepatol 3 99-106
[7]
Hoffman JM(2015)Cost-effectiveness analysis of linezolid versus vancomycin in hospital-acquired pneumonia caused by methicillin-resistant JoHTA 92 235-242
[8]
Haidar CE(2012)Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping Clin Pharmacol Ther 55 89-106
[9]
Wilkinson MR(2015)Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers Annu Rev Pharmacol Toxicol 89 25-33
[10]
Crews KR(2014)Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol Mayo Clin Proc 95 423-431